NCT07629401|Unknown
Provide Pre-approval Expanded Access of LY3437943
2 other identifiers
27979J1I-MC-Y001
Study Type
expanded_access
Target
N/A
Locations
0 countries
Sites
N/A
Timeline
RegisteredJun 2026
Brief Summary
Provide pre-approval single patient expanded access of retatrutide for patients.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 1, 2026
Completed4 days until next milestone
First Posted
Study publicly available on registry
June 5, 2026
CompletedLast Updated
June 5, 2026
Status Verified
June 1, 2026
First QC Date
June 1, 2026
Last Update Submit
June 1, 2026
Interventions
RetatrutideDRUG
Also known as: LY3437943
Eligibility Criteria
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
retatrutide
Central Study Contacts
Study Design
- Study Type
- expanded access
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 1, 2026
First Posted
June 5, 2026
Last Updated
June 5, 2026
Record last verified: 2026-06